Derm, Case-Based-Roundtable | Virtual - Texas

Risk Refined: Leveraging Gene Expression Profile Testing to Guide Skin Cancer Care

May 28th | 5:30 PM CT

Moderated by Andrew Baker, PA-C

Virtual

Join Dermatology Times for a collaborative, small-group meeting designed around case-based clinical profiles and peer-dialogue led by an expert clinicians. This session offers practicing dermatology clinicians* the perfect opportunity to sharpen their skills and expertise in treatment strategies.

*To be eligible to attend this meeting, clinicians must be a practicing dermatologist, or advanced practitioner in dermatology in the US.

Objectives:

· Discuss the current staging systems utilized to guide melanoma and squamous cell carcinoma treatment and the limitations and challenges associated with these current systems. · Highlight the utility of gene expression profile testing to enhance risk stratification and personalize treatment decisions in melanoma and squamous cell carcinoma. · Explore how gene expression profiling might be implemented into clinical practice through case-based discussion.

Moderator

Andrew Baker, PA-C

MEETING DETAILS

DATE & TIME

May 28, 2025

5:30 PM - 7:30 PM CT

EVENT VENUE

Virtual

MARKET RESEARCH PARTICIPATION

This event is held in partnership with Healthcare Research & Analytics (HRA®) to gain market research insights into health care professional’s educational needs in their current practice setting.

HRA® offers compensation of $500 to clinicians for your consultative contributions during the event discussions and completion of a post-event survey.

Dermatology Times® — an MJH Life Sciences Brand

Terms & Conditions

Do Not Sell My Info